An Estrogen-regulated Long Non-coding RNA NCALD Promotes Luminal Breast Cancer Proliferation by Activating GRHL2

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2024 Jan 30

PMID 38291441

Authors

Yue Meng

Dianrong Zhou

Ying Luo

Jierong Chen

Hui Li

Affiliations

Soon will be listed here.

Abstract

Purpose: Luminal breast cancer (BC) is a prevalent subtype associated with an increased risk of late disease recurrence and mortality. Long noncoding RNAs (lncRNAs) likely play significant roles in regulating tissue-specific gene expression during tumorigenesis. However, the biological function and underlying mechanisms of specific dysregulated lncRNAs in luminal BC remain largely unknown, which has drawn our attention.

Methods: The expression pattern of lncRNA NCALD in luminal BC was predicted and validated in collected tissue samples. Following cell transfection with knockdown of lncRNA NCALD and ESR1 and overexpression of GRHL2 and ESR1, we investigated the interactions among lncRNA NCALD, ESR1, and GRHL2. Additionally, their regulatory functions in luminal BC cell biological processes were studied. Subsequently, a xenograft tumor model was prepared for validation.

Results: Our study identified a specific overexpression of the lncRNA NCALD in luminal BC, which correlated with an unfavorable prognosis. Suppression of lncRNA NCALD or ESR1 led to inhibition of GRHL2 expression, while concurrent overexpression of ESR1 and lncRNA NCALD potentially elevated GRHL2 expression. Mechanistically, ERα may drive the expression of lncRNA NCALD. Furthermore, the 1-151 nt fragment of lncRNA NCALD was found to recruit ERα and interact with its oest-Recep domain located in the promoter region of GRHL2, ultimately inducing GRHL2 transcription.

Conclusions: These findings reveal the involvement of lncRNA NCALD and its specific expression pattern in luminal BC. Targeting lncRNA NCALD could be a potential therapeutic strategy for delaying the progression of BC.

References

Bjorklund S, Aure M, Hakkinen J, Vallon-Christersson J, Kumar S, Evensen K . Subtype and cell type specific expression of lncRNAs provide insight into breast cancer. Commun Biol. 2022; 5(1):834. PMC: 9388662. DOI: 10.1038/s42003-022-03559-7. View

Jiang Y, Jiang Y, Xie J, Mayakonda A, Hazawa M, Chen L . Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat Commun. 2018; 9(1):3619. PMC: 6127298. DOI: 10.1038/s41467-018-06081-9. View

Xiang X, Deng Z, Zhuang X, Ju S, Mu J, Jiang H . Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS One. 2013; 7(12):e50781. PMC: 3524252. DOI: 10.1371/journal.pone.0050781. View

Jiang G, Wang X, Sheng D, Zhou L, Liu Y, Xu C . Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function. Theranostics. 2019; 9(22):6501-6516. PMC: 6771234. DOI: 10.7150/thno.34874. View

Gupta R, Shah N, Wang K, Kim J, Horlings H, Wong D . Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464(7291):1071-6. PMC: 3049919. DOI: 10.1038/nature08975. View

Wilkinson L, Gathani T . Understanding breast cancer as a global health concern. Br J Radiol. 2021; 95(1130):20211033. PMC: 8822551. DOI: 10.1259/bjr.20211033. View

Gray J, Wani S, Campbell M . Epigenomic alterations in cancer: mechanisms and therapeutic potential. Clin Sci (Lond). 2022; 136(7):473-492. DOI: 10.1042/CS20210449. View

Meng Y, Wang L, Xu J, Zhang Q . AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity. Mol Oncol. 2018; 12(3):373-390. PMC: 5830630. DOI: 10.1002/1878-0261.12171. View

Zhang J, Fan D, Jian Z, Chen G, Lai P . Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma. PLoS One. 2015; 10(10):e0141042. PMC: 4619599. DOI: 10.1371/journal.pone.0141042. View

10.

Khatpe A, Adebayo A, Herodotou C, Kumar B, Nakshatri H . Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer. Cancers (Basel). 2021; 13(3). PMC: 7864210. DOI: 10.3390/cancers13030369. View

11.

Kumegawa K, Takahashi Y, Saeki S, Yang L, Nakadai T, Osako T . GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer. NPJ Breast Cancer. 2022; 8(1):70. PMC: 9177858. DOI: 10.1038/s41523-022-00438-6. View

12.

Rossi L, Mazzara C, Pagani O . Diagnosis and Treatment of Breast Cancer in Young Women. Curr Treat Options Oncol. 2019; 20(12):86. DOI: 10.1007/s11864-019-0685-7. View

13.

Sonnenblick A, Salgado R, Brohee S, Zahavi T, Peretz T, Van den Eynden G . p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. Int J Oncol. 2017; 52(2):424-432. PMC: 6903891. DOI: 10.3892/ijo.2017.4212. View

14.

Chi D, Singhal H, Li L, Xiao T, Liu W, Pun M . Estrogen receptor signaling is reprogrammed during breast tumorigenesis. Proc Natl Acad Sci U S A. 2019; 116(23):11437-11443. PMC: 6561257. DOI: 10.1073/pnas.1819155116. View

15.

McHugh C, Chen C, Chow A, Surka C, Tran C, McDonel P . The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015; 521(7551):232-6. PMC: 4516396. DOI: 10.1038/nature14443. View

16.

Zhang Y, Huang Y, Wang D, Yang B, Yan H, Lin L . LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network. Theranostics. 2020; 10(23):10823-10837. PMC: 7482804. DOI: 10.7150/thno.47830. View

17.

Xiao T, Li W, Wang X, Xu H, Yang J, Wu Q . Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proc Natl Acad Sci U S A. 2018; 115(31):7869-7878. PMC: 6077722. DOI: 10.1073/pnas.1722617115. View

18.

Zhang Q, Liu W, Zhang H, Xie G, Miao Y, Xia M . hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020; 18(2):120-128. PMC: 7647694. DOI: 10.1016/j.gpb.2019.09.006. View

19.

Zhou K, Liu S, Sun W, Zheng L, Zhou H, Yang J . ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucleic Acids Res. 2016; 45(D1):D43-D50. PMC: 5210649. DOI: 10.1093/nar/gkw965. View

20.

Cieply B, Farris J, Denvir J, Ford H, Frisch S . Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. Cancer Res. 2013; 73(20):6299-309. PMC: 3806457. DOI: 10.1158/0008-5472.CAN-12-4082. View